Spe­cial re­port: Twen­ty ex­tra­or­di­nary women blaz­ing trails in bio­phar­ma R&D — Covid-19 and be­yond

In the sec­ond year of End­points News’  bud­ding tra­di­tion of high­light­ing women blaz­ing trails in bio­phar­ma R&D, we’ve seen a num­ber of firsts.

For the first time, the biggest sto­ry in R&D is al­so top of mind for a world anx­ious to end the most dev­as­tat­ing health cri­sis in decades. With its sweep­ing ef­fects, the Covid-19 pan­dem­ic is turn­ing the dai­ly rou­tines for many work­ing women up­side down, tak­ing a toll on not just their phys­i­cal and men­tal health, but al­so their ca­reer prospects. At the same time, the biotech in­dus­try is do­ing some se­ri­ous soul search­ing with a new score­card and plan for di­ver­si­ty and in­clu­sion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.